Ever Source Wealth Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 247 shares of ARWR stock, worth $4,065. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247
Previous 118
109.32%
Holding current value
$4,065
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$258 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$217 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$183 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$115 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$86.1 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.74B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...